Junli Zuo1,2, Shaoli Chu1, Isabella Tan3, Mark Butlin3, Jiehui Zhao4, Alberto Avolio3. 1. Department of Hypertension, Ruijin Hospital North, Shanghai Jiaotong University School of Medicine, Shanghai, PR China. 2. Department of Geriatrics, Ruijin Hospital North, Shanghai Jiaotong University School of Medicine, Shanghai, PR China. 3. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia. 4. Department of The Department of Geriatric Nursing Hospital, Baohua, Shanghai, PR China.
Abstract
BACKGROUND: Central aortic pressure has often been shown to be more closely associated with markers of vascular function and incidence of cardiovascular events compared to peripheral pressure. However, the potential clinical use of central aortic or peripheral haemodynamic indices as markers of target organ damage (TOD) has not been fully established. METHODS: We evaluated associations of TOD with central aortic and peripheral haemodynamic indices (central aortic [cPP] and peripheral pulse pressure [pPP], central aortic augmentation index, and central and peripheral waveform factor) in 770 hospital inpatients (age 60 ± 10 years, 473 males) with primary hypertension. TOD was quantified in terms of arterial stiffness as measured by carotid-femoral pulse wave velocity (cfPWV), carotid intima-media thickness (IMT), and urine albumin-to-creatinine ratio (ACR). Subclinical TOD was defined as carotid IMT >0.9 mm, urine ACR >3.5 mg/mmol in females and >2.5 mg/mmol in males and/or cfPWV >12 m/s. RESULTS: Both cPP and pPP showed significant correlation with cfPWV (r = 0.41 vs. 0.40; p < 0.01), ACR (r = 0.24 vs. 0.27; p < 0.01) and carotid IMT (r = 0.14 vs. 0.15; p < 0.01). Each SD increase in pPP and cPP was associated with increased risk of cfPWV >12 m/s (odds ratio [OR] = 2.7 and 2.9 for pPP and cPP, respectively), ACR >2.5 mg/mmol (OR = 1.2 and 1.4, respectively), and carotid IMT >0.9 mm (OR = 1.46 and 1.53, respectively). Compared to pPP, cPP had higher predictive power for TOD for age ≥60 years (OR = 3.07, p < 0.001). CONCLUSIONS: Although both pPP and cPP show an association with TOD in a hypertensive population, cPP provides additional information beyond pPP associated with TOD in a hypertensive cohort. Central aortic haemodynamic indices as potential biomarkers of subclinical TOD need to be validated by further prospective studies.
BACKGROUND: Central aortic pressure has often been shown to be more closely associated with markers of vascular function and incidence of cardiovascular events compared to peripheral pressure. However, the potential clinical use of central aortic or peripheral haemodynamic indices as markers of target organ damage (TOD) has not been fully established. METHODS: We evaluated associations of TOD with central aortic and peripheral haemodynamic indices (central aortic [cPP] and peripheral pulse pressure [pPP], central aortic augmentation index, and central and peripheral waveform factor) in 770 hospital inpatients (age 60 ± 10 years, 473 males) with primary hypertension. TOD was quantified in terms of arterial stiffness as measured by carotid-femoral pulse wave velocity (cfPWV), carotid intima-media thickness (IMT), and urine albumin-to-creatinine ratio (ACR). Subclinical TOD was defined as carotid IMT >0.9 mm, urine ACR >3.5 mg/mmol in females and >2.5 mg/mmol in males and/or cfPWV >12 m/s. RESULTS: Both cPP and pPP showed significant correlation with cfPWV (r = 0.41 vs. 0.40; p < 0.01), ACR (r = 0.24 vs. 0.27; p < 0.01) and carotid IMT (r = 0.14 vs. 0.15; p < 0.01). Each SD increase in pPP and cPP was associated with increased risk of cfPWV >12 m/s (odds ratio [OR] = 2.7 and 2.9 for pPP and cPP, respectively), ACR >2.5 mg/mmol (OR = 1.2 and 1.4, respectively), and carotid IMT >0.9 mm (OR = 1.46 and 1.53, respectively). Compared to pPP, cPP had higher predictive power for TOD for age ≥60 years (OR = 3.07, p < 0.001). CONCLUSIONS: Although both pPP and cPP show an association with TOD in a hypertensive population, cPP provides additional information beyond pPP associated with TOD in a hypertensive cohort. Central aortic haemodynamic indices as potential biomarkers of subclinical TOD need to be validated by further prospective studies.
Authors: Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stephane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad Journal: Blood Press Date: 2013-12-20 Impact factor: 2.835
Authors: Thomas Weber; Marcus Ammer; Martin Rammer; Audrey Adji; Michael F O'Rourke; Siegfried Wassertheurer; Stefan Rosenkranz; Bernd Eber Journal: J Hypertens Date: 2009-08 Impact factor: 4.844
Authors: J Abellán-Huerta; L Prieto-Valiente; L Consuegra-Sánchez; S Montoro-García; A B Salguero-Merino; R Morales-López; J Abellán-Alemán; F Soria-Arcos Journal: Hipertens Riesgo Vasc Date: 2017-05-15
Authors: Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Michael H Olsen Journal: J Hypertens Date: 2009-06 Impact factor: 4.844
Authors: Mohamed Temmar; Piotr Jankowski; Marcel Peltier; Vincent Mouquet; Dorota Debicka-Dabrowska; Farah Hamida; Kalina Kawecka-Jaszcz; Michel E Safar Journal: Hypertension Date: 2010-01-04 Impact factor: 10.190
Authors: Anna Oliveras; Luis García-Ortiz; Julián Segura; José R Banegas; Nieves Martell-Claros; Luis Vigil; Carmen Suarez; Manuel Á Gomez-Marcos; María Abad-Cardiel; Susana Vazquez; Juan J de la Cruz; Stanley S Franklin; Luis M Ruilope; Alejandro de la Sierra Journal: J Hypertens Date: 2013-01 Impact factor: 4.844
Authors: Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson Journal: Eur Heart J Date: 2014-01-23 Impact factor: 29.983
Authors: James E Sharman; Alberto P Avolio; Johannes Baulmann; Athanase Benetos; Jacques Blacher; C Leigh Blizzard; Pierre Boutouyrie; Chen-Huan Chen; Phil Chowienczyk; John R Cockcroft; J Kennedy Cruickshank; Isabel Ferreira; Lorenzo Ghiadoni; Alun Hughes; Piotr Jankowski; Stephane Laurent; Barry J McDonnell; Carmel McEniery; Sandrine C Millasseau; Theodoros G Papaioannou; Gianfranco Parati; Jeong Bae Park; Athanase D Protogerou; Mary J Roman; Giuseppe Schillaci; Patrick Segers; George S Stergiou; Hirofumi Tomiyama; Raymond R Townsend; Luc M Van Bortel; Jiguang Wang; Siegfried Wassertheurer; Thomas Weber; Ian B Wilkinson; Charalambos Vlachopoulos Journal: Eur Heart J Date: 2017-10-01 Impact factor: 29.983